Share Twitter LinkedIn Facebook Email Swetha Kambhampati, MD from the City of Hope talks about the ASCO 2023 abstract about Mantle Cell Lymphoma Real-World Outcomes of Brexu-cel A CIBMTR Subgroup Analysis by Prior Treatment. ASCO 2023 Brexu-cel Brexucabtagene Autoleucel CIBMTR Subgroup Analysis City of Hope Mantle Cell Lymphoma Swetha Kambhampati
FDA Approves Adcetris / brentuximab vedotin + lenalidomide & rituximab in relapsed or refractory LBCL: Could This Change Standard Care? Lymphoma 2 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read